Lilly Profit Misses Estimates as Generic Drugs Cut Sales

Published October 24, 2012

Lilly Profit Misses Estimates as Generic Drugs Cut Sales

Filed under: drug treatment programs in nyc

(LLY) reported third- quarter earnings that missed analyst estimates after generic competition reduced revenue from the schizophrenia treatment Zyprexa, once the company's top-selling drug. Earnings … Lilly fell 2.7 percent to $ 50.50 at the close in …
Read more on Bloomberg

EU gives Pfizer cancer drug conditional approval

Filed under: drug treatment programs in nyc

NEW YORK (AP) — Drug giant Pfizer Inc. said Wednesday that it's received conditional approval to market its lung cancer pill Xalkori for certain patients in the European Union. The drug, also known by the chemical name crizotinib, is for adults who …
Read more on Businessweek